Learning Objectives:

1. Discuss the ADA recommendations for glucagon-like peptide-1 (GLP-1) receptor agonist and sodium-glucose cotransporter-2 (SGLT2) inhibitor use

2. Identify resources available for medication access assistance

3. Understand how to implement new ADA diabetes management guidelines into daily practice

Session date: 
07/27/2021 - 7:00am to 8:00am CDT
UChicago Care Network - Primary Care
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Sarah Pérez, PharmD, BCACP, AAHIVP